This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Quest Diagnostics Care360 Is Top EHR, As Ranked By Doctors In 2013 Black Book Survey

Stocks in this article: DGX

MADISON, N.J., Aug. 14, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Care360 cloud-based electronic health record (EHR) has ranked number one in several categories in the Black Book 2013 Rankings of EHRs in the replacement market. The ranking is based on polling and surveys of 2,880 physicians in the United States interested in replacing their current EHR with a more advanced system.

(Logo: http://photos.prnewswire.com/prnh/20130717/NY48934LOGO)

Care360 ranked number one in overall satisfaction across all physician practices, practice sizes and specialties. This ranking includes assessments of EHR functionality, innovation and Meaningful Use. The system also ranked number one for mobile innovation and access, and received the highest possible score of 'A' in each of all seven categories evaluated, including interoperability and connectivity.

A summary of the report, " 2013 State of the Ambulatory Electronic Health Records Replacement Market," is available at www.Care360.QuestDiagnostics.com/Black-Book.cfm.

"Eighty-eight percent of all surveyed physician practices evaluating EHR replacement options cited Care360 as meeting or exceeding their requirements, particularly in the areas of system usability and innovation, regardless of their current vendor," said Doug Brown, managing partner of Black Book. "As providers look beyond basic EHR platforms to the more complex requirements surrounding Stage 2 and Stage 3 of Meaningful Use, Health Information Exchanges, ICD-10, and Accountable Care initiatives, they increasingly require solutions with flexible, robust data sharing capabilities that can help them achieve their business goals. Care360's high marks in our survey suggest it is well regarded as an option by providers seeking to upgrade their current EHR with a more advanced offering."

"The Care360 EHR was easy to implement," said Emilia E. Murray, M.D., of Naples, Florida, whose internal medicine practice switched to Care360 after trying two other EHR systems. "Because it's cloud-based, it is very user-friendly and very reasonably priced. Care360 is accessible from the office, hospital, or home and the iPad application is very helpful. I was able to achieve Meaningful Use within a few months of setting up Care360 EHR."

"Quest Diagnostics is committed to innovative connectivity solutions that help physicians harness the power of diagnostic and other health information to promote favorable outcomes for patients," said Philip S. Present II, vice president and general manager, healthcare information technology, Quest Diagnostics. "It is gratifying that physicians across the U.S. regard Care360 as an advanced technology that is interoperable with other systems, facilitates secure any-time access on mobile devices, and enables them to run a productive, quality practice."

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,814.94 -2.96 -0.02%
S&P 500 2,067.03 -2.38 -0.12%
NASDAQ 4,758.2520 +3.36 0.07%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs